As long as pharmaceutical tariffs are being considered, their potential threat to the pharmaceutical industry and the people ...

Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.

Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...

CLSA said that even if tariffs are imposed, Indian drug makers are likely to pass on the costs, given their dominant market ...

As per an analysis of the GTRI, the hardest-hit sector in agriculture would be fish, meat, and processed seafood, with $2.58 ...

Indian pharmaceutical exports to the U.S. were valued at approximately USD 8 billion, with the industry witnessing an 8 percent compound annual growth rate (CAGR) over FY15-24.

"Ceramic, glass, and stone products, with USD 1.71 billion in exports, will face an 8.27 per cent tariff, impacting demand.

GROUPE LSL PHARMA INC (TSXV: LSL) (TSXV: LSL.DB) (the "Company" or "LSL Pharma"), a Canadian integrated pharmaceutical ...

The recent imposition of a 27 per cent reciprocal tariff on Indian exports by the United States, while exempting the ...

Pharma: However, to fully leverage these opportunities, India has to enhance its ease of doing business, invest in logistics ...

Trump imposed a 10% tariff on most U.S. imports, as well as much higher levies on dozens of rivals and allies alike, but ...

Experts warn that U.S. reciprocal tariffs on Indian goods could impact various sectors, including agriculture, pharma, and ...